Table of Contents
ISRN Oncology
Volume 2012 (2012), Article ID 159568, 6 pages
http://dx.doi.org/10.5402/2012/159568
Clinical Study

Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

1Barbara Ann Karmanos Cancer Institutte, Wayne State University School of Medicine, Detroit, MI 48201, USA
2Division of Hematology/Oncology, St. John Hospital, Wayne State University School of Medicine, 19229 Mack Avenue, Grosse Pointe Woods, Detroit, MI 48236, USA

Received 1 January 2012; Accepted 22 January 2012

Academic Editors: M. Emoto and M. Santarosa

Copyright © 2012 Zyad Kafri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Zyad Kafri, Lance K. Heilbrun, Ammar Sukari, et al., “Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck,” ISRN Oncology, vol. 2012, Article ID 159568, 6 pages, 2012. doi:10.5402/2012/159568